Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Smart Eye launches new technology – say hi to the AI-X

Today, Smart Eye’s business area Research Instruments releases a pioneering product, the AI-X. Based on Smart Eye’s extensive experience within the automotive industry, the AI-X is a standardized, yet high performing eye tracker developed for commercial research.For over 20 years, Smart Eye has gathered experience from the automotive industry, combining a high performing solution in a cost-effective way. This knowledge is now packaged for the research field in the form of AI-X, perfectly suitable for various large studies with many subjects. The AI-X is the next generation of Smart Eye’s

Interim report January – March 2020

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value fell to SEK 114 per share, compared with SEK 136 per share at the start of the year. This is a decrease of 16.2 per cent. By comparison, the Stockholm Stock Exchange's Total Return Index (SIXRX) decreased by 18.2 per cent. The net asset value was SEK 122 per share at 27 April.1) · In the first quarter, the total return on the Latour share amounted to -7.3 per cent measured against the SIXRX, which was down 18.2 per cent. INDUSTRIAL OPERATIONS · The industrial operations' order intake rose 20 per cent to SEK 3,996 m (

Stora Enso appoints Lars Völkel as Head of Wood Products division

STORA ENSO OYJ STOCK EXCHANGE RELEASE 28 April 2020 at 9.30 EESTStora Enso has appointed Lars Völkel as EVP, Head of Wood Products division and a member of the Group Leadership Team. He will start on 1 July 2020 and be based in Stockholm. Lars Völkel is a German citizen who is currently the CEO of Ambibox GmbH, a renewable energy & electronic vehicle charging company in Germany. Previously he has worked as CEO at the Swiss company Franke Kitchen Systems, and as EVP Luxury retail & CEO of Poggenpohl at the European kitchen group Nobia. He has also held various managerial positions at

Polygiene ViralOff technology takes off with early adapters Maloja and other global brands

Malmö, Sweden (April 28, 2020) – Polygiene, the global leader in branded odor control and stays fresh technologies continues to advance the development and production of ViralOff® technology that reduces over 99% of viruses in two hours* on treated fabrics. ViralOff launched on April 7[th], is now coming to market with multiple early adapters to combat the novel corona virus. ViralOff provides brands a technology that can be applied to textiles, that can be utilized for garments, gear or accessories to minimize the potential risks of having viruses in the fabric. ViralOff is made

Interim Report 1 January – 31 March 2020

”High demand and strong profit growth!” 1 JANUARY – 31 MARCH 2020 (3 MONTHS) · Net sales increased by 25 percent to SEK 1,053 million (845), of which organic growth amounted to 12 percent and acquired growth amounted to 13 percent. · EBITA increased by 51 percent to SEK 106 million (70), corresponding to an EBITA-margin of 10.0 percent (8.3). · Profit after tax increased by 54 percent to SEK 54 million (35). · Earnings per share amounted to SEK 1.92 (1.32). Earnings per share for the last 12 months amounted to 5.73 SEK (5.12). · Cash flow from operating activities

Invitation to conference call with web presentation of AcadeMedia's quarterly report for July – March 2019/20

AcadeMedia's quarterly report for July – March 2019/20 will be published at 08:00 CEST on 5 May. A web-cast telephone conference will be held at 09:30 CEST the same day, where CEO Marcus Strömberg and CFO Katarina Wilson will present the report.The presentation will be held in English and can be followed on the web or over the phone. It will be followed by a Q&A session. To participate in the conference call, and thereby be able to ask questions, call one of the following numbers ten minutes before the start of the call: SE: +46 8 5199 93 83UK: +44 33 3300 9273US: +1 833 8230 586

Interim Report January – March 2020

STABLE DEVELOPMENT IN THE FIRST QUARTERRevenue increased to SEK 3,814m (3,669), and revenue excluding JM Construction, Business area Construction (under closure), amounted to SEK 3,768m (3,719). Operating profit increased to SEK 483m (313)[1)]. The operating margin increased to 12.7 percent (8.5). Operating profit excluding JM Construction, Business area Construction, amounted toSEK 491m (506) and the operating margin to 13.0 percent (13.6). Profit before tax increased to SEK 462m (291). Profit after tax increased to SEK 364m (228). Return on equity for the past twelve months

Hansa Biopharma interim report Jan-Mar 2020. EMA process on track; an opinion from the CHMP is expected in the second quarter 2020.

•    A formal adoption of outstanding questions, incl. definition of patients and design of the post approval study, expected at the CHMP April session. •    The study protocol for a new US trial is expected to be submitted in Q2 2020.Lund April 28, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and interim report for the first quarter 2020. Highlights for the first quarter 2020 · The ongoing review of the MAA for imlifidase in Europe by EMA is on track. Responses to Day 180 questions were

ICA’s new climate ambition: Cut customers’ climate impact in half and achieve at least neto zero impact by 2030

ICA will achieve its previously set climate target to be climate-neutral by 2020, based on existing plans for the year*. ICA is now taking the next step to achieve entirely on its own at least a neto zero impact by 2030 and thereby continue to have an ambitious and responsible climate ambition based on leading climate research and the Paris Agreement. A large share of the global climate impact comes from the production and consumption of food. ICA has previously included suppliers in its sustainability work and will now be intensifying this work by adopting the ambition to cut the climate

TDL Canada enters distribution agreement with InCoax for the in:xtnd [TM]

The Canadian distributor TDL  enters agreement for nationwide distribution of in:xtnd[TM] Ethernet extension system over coax. TDL is a premier national tech distributor since 1979.  They are well-established and trusted, operating out of multiple offices and warehouse sites across the country.During the +40 years in operation, they have gained in-depth knowledge of the market, and built up a solid and loyal customer base. TDL markets themselves as a ”Customer-Comes-First” distribution company serving integrators, service providers, E‑Commerce fulfillment &

Write-down of deferred tax assets in Clavister in the fourth quarter

Örnsköldsvik, Sweden, April 28, 2020. The Board of Directors of Clavister Holding AB decided today to write down a deferred tax receivable in Clavister AB of total SEK 47.4 million. The non-cash-flow impairment charge is charged to the result in the last quarter of 2019. According to applicable accounting rules, the company needs to prove taxable profits in the near future to justify the asset. However, Clavister still has the opportunity to claim that previously accumulated deficits are offset against future taxable profits. All figures are revised. For additional information

Interim report, January–March 2020

Progress in a turbulent worldJanuary–March 2020 · Revenue increased to TSEK 59,576 (53,361). · Operating profit increased to TSEK 5,355 (4,660). · Profit after tax increased to TSEK 33,705 (21,333). · Earnings per share increased to 0.98 SEK (0.71). Significant events during the period · Directed new share issue of approx. SEK 84.5 million to Stena Finans AB. · New distributors in Benelux, Colombia and Peru. · Ozone’s mobile broadband service via satellite in use by Italian authorities in the work of limiting the spread of Covid-19. · Secured renewed contracts,

Travel from home with Amazing Thainess

Tourism Authority of Thailand invite you to join us on a journey with Travel from home with Amazing Thainess. Spring is finally here. Normally, we would have planned our travelling vacation already. This year is a little bit different and we are now facing the “new normal” where we are unlikely to be travelling out of the country during this summer. This condition should not limit all the travel lovers to explore and get inspired with new destinations to add on the bucket list. But it’s time to do more researches, finding new unexplored cities, or even fall in love again with

Alps Alpine and TactoTek® Deliver In-Mold Electronics HMI Solution for Premium German Automotive OEM

Collaborative solution development paves way for expanding the use of TactoTek IMSE™ technologyOULU, FINLAND/TOKYO, JAPAN (28 April 2020) – Today, TactoTek, the Finland-based company that develops, industrializes and licenses in-mold structural electronics (IMSE™), and Alps Alpine, a designer and manufacturer of high-quality electronic products, announced that they have collaborated to develop an IMSE human-machine interface (HMI) solution for a premium German automotive OEM. In this project, Alps Alpine started the development with the industrial design and HMI of an existing serial

Interim Report Q1 2020

A good start to the year despite COVID-19 Q1 2020 highlights · Total net revenues of SEK 175.0 m (174.3), up 0.4 percent · EBITDA of SEK 39.1 m (12.0), up 225.8 percent  · Net earnings of SEK 82.6 m (14.1), up 485.8 percent · US Pharma (Zubsolv® US) net revenues of SEK 163.9 m (161.7), up 1.3 percent in SEK and -4.0 percent in local currency. HQ & Pipeline net revenues of SEK 11.1 m (12.6). · US Pharma (Zubsolv US) EBIT of SEK 75.9 m (68.2), up 11.2 percent, Digital Therapeutics EBIT of SEK -12.0 m (-) and HQ & Pipeline EBIT of SEK -29.9 m (-67.1) · Cash flow from

Semcon Interim Report January-March 2020

Strong quarter despite change in market situationFirst quarter  · The operating income amounted to SEK 491 million (483) and the organic growth was 1.3% · The operating profit amounted to SEK 50 million (44), yielding an operating margin of 10.2% (9.1) · The profit after tax amounted to SEK 38 million (33)  · Earnings per share (EPS) after dilution amounted to SEK 2.14 (1.83) Comment from CEO Markus Granlund:  The year began in much the same way as 2019 ended – with further improvements in earnings and an operating margin over 10 per cent. Rising demand for product

Midsona - Interim report Jan-March 2020

Organic sales growth and significantly improved EBITDAJanuary-March 2020 (first quarter) · Net sales amounted to SEK 946 million (786). · EBITDA amounted to SEK 107 million (73) before items affecting comparability, corresponding to a margin of 11.3 percent (9.3). · Profit for the period was SEK 47 million (4), corresponding to earnings per share of SEK 0.72 (0.08) before and after dilution. · Free cash flow amounted to SEK 2 million (-42). · Midsona had a higher demand for its products in the month of March in all geographic markets, which can be traced to the

Armin Busen joins Stillfront Group as Senior Vice President Business Operations

Stillfront today announced that Armin Busen will join Stillfront as Senior Vice President Business Operations and member of the Group´s business management team. Armin is currently Chief Product Officer, CPO of InnoGames and has 15 years background in the online and media business. Armin has extensive experience in corporate and high growth companies and has held various executive positions. As CPO with InnoGames, Armin has been managing the gaming studios including portfolio development and platform strategy and he has a proven record of establishing organizational structures for

Vicore Pharma gets regulatory approval to start phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection

Gothenburg, April 28, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces the approval by the UK regulatory agency (MHRA[1]) of the clinical trial application (CTA) for a phase II study with the proprietary compound VP01 (C21) in patients with COVID-19, SARS CoV-2 infection.Only four weeks after submitting a Letter of Intent to file a CTA to start the process, Vicore Pharma has completed the submission and gained approval from the agency to start the study. The study, named ATTRACT (

SAS INITIATES PROCESSES TO REDUCE THE SIZE OF ITS FUTURE WORKFORCE DUE TO LOWER EXPECTED DEMAND FOR AIR TRAVEL

As a result of COVID-19, demand is expected to be significantly affected during the remainder of 2020 and it will take some years before demand returns to the levels experienced before the outbreak. Consequently, SAS needs to adapt the business to a lower demand environment. As a consequence, SAS will initiate processes to reduce the size of its future workforce by up to 5,000 full-time positions.The COVID-19 outbreak has removed most of the demand for air travel and thereby the commercial basis for airlines.  Currently, SAS is only operating a very limited domestic network in Norway and

Wallenstam’s Interim report Jan 1–Mar 31, 2020: Wallenstam stands strong even in the crisis

Hans Wallenstam, CEO, comments on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CEST) at the latest. An audiocast in English with Susann Linde, CFO and Head of Investor Relations, will take place at 16.00 (CEST) at www.financialhearings.com. The presentation is available at www.wallenstam.se/filmsandpresentations before 16:00 (CEST). January 1–March 31, 2020 · The net asset value per share increased by SEK 1.25 during the period and amounted to SEK 92.60 (83.60).  · Income from property management increased by about 6 percent and

Interim report January-March 2020

Improved operating profit and continued favourable growth in the first quarter· Net sales for Ratos’s business areas increased by 7%, of which 10% comprised organic growth, and amounted to SEK 5,584m (5,210) · EBITA for Ratos’s business areas amounted to SEK 107m (75) · Operating profit for the Ratos Group amounted to SEK 61m (27) · Net cash in the parent company totalled SEK 1,391m · Diluted earnings per share amounted to SEK -0.38 (-0.35) At 10.00 CET a telephone conference will be held, participant connection: UK: +44 33 3300 9264, SE: +46 8 505 583 74, US: +1 833 249 8405.

Solteq Plc has signed delivery and service agreements worth around EUR 8 million (including options) with the energy industry

Solteq Plc, Inside information, April 28, 2020 at 8.55 am Solteq Plc has signed on March 31[st] and April 27[th] 2020 delivery and service agreements, worth around EUR 8 million, with two Finnish energy industry customers. The agreements cover deliveries of the customer information system developed by Solteq, including related options (worth around EUR 2.1 million), and license service fees for 4–5 years. Distribution: NASDAQ OMX HelsinkiKey mediawww.solteq.com

Frill Holding AB conducts rights issue of SEK 15 million for implementation of a new strategy

STOCKHOLM, Tuesday, April 28, 2020 7:50 CET    Summary · The Board of Directors of Frill Holding AB proposes a partially guaranteed rights issue of approximately SEK 15.15 million. The issue is guaranteed to the amount of SEK 12 million. · The Extraordinary General Meeting will be held on 18 May 2020 for approval of the rights issue.  · The rights issue will ensure an intensified investment in Frill by a revised product and marketing strategy. · Financial target to achieve positive cash flow in 2021. Background to the Rights IssueIn 2019, Frill Holding AB ("Frill or

There are no items matching the current filter
There are no more items matching the current filter
Back to top